This announcement is a separate document:
奥泰生物：深圳价值在线咨询顾问有限公司关于杭州奥泰生物技术股份有限公司2022年限制性股票激励计划首次授予第二个归属期符合归属条件事项之独立财务顾问报告
Aotai Biotech: Shenzhen Value Online Consulting Co., Ltd.\'s independent financial advisory report on how Hangzhou Aotai Biotechnology Co., Ltd. was granted for the first time in the 2022 Restricted Stock Incentive Plan to meet the eligibility requirements for the second vesting period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated